Skip to main content
letter
. 2021 Jul 17;398(10298):385–387. doi: 10.1016/S0140-6736(21)01642-1

Figure.

Figure

Levels of antibody against the spike glycoprotein of SARS-CoV-2 (S-antibody) at defined timepoints after second dose of vaccination (with extended dose intervals) in individuals with no previous infection, stratified by vaccine type

p values derived from non-parametric tests for trend for each vaccine subgroup are given in parenthesis in the key.